These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8099774)

  • 21. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pentylenetetrazol-induced seizures affect the levels of prolyl oligopeptidase, thimet oligopeptidase and glial proteins in rat brain regions, and attenuation by MK-801 pretreatment.
    Ahmed MM; Arif M; Chikuma T; Kato T
    Neurochem Int; 2005 Sep; 47(4):248-59. PubMed ID: 15985312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells.
    Jiménez A; Jordà EG; Verdaguer E; Pubill D; Sureda FX; Canudas AM; Escubedo E; Camarasa J; Camins A; Pallàs M
    Toxicol Appl Pharmacol; 2004 Apr; 196(2):223-34. PubMed ID: 15081269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MK-801 antagonizes methamphetamine-induced decreases in hippocampal and striatal corticosteroid receptors.
    Lowy MT
    Brain Res; 1990 Nov; 533(2):348-52. PubMed ID: 2289150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ; Abbate GM; Black CK; Taylor VL
    J Pharmacol Exp Ther; 1990 Nov; 255(2):478-83. PubMed ID: 1978728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan.
    Farfel GM; Seiden LS
    J Pharmacol Exp Ther; 1995 Feb; 272(2):868-75. PubMed ID: 7853205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.
    Thomas DM; Dowgiert J; Geddes TJ; Francescutti-Verbeem D; Liu X; Kuhn DM
    Neurosci Lett; 2004 Sep; 367(3):349-54. PubMed ID: 15337264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotoxic amphetamine analogues: effects in monkeys and implications for humans.
    Ricaurte GA; McCann UD
    Ann N Y Acad Sci; 1992 May; 648():371-82. PubMed ID: 1379014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
    Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents.
    Chipana C; Torres I; Camarasa J; Pubill D; Escubedo E
    Neuropharmacology; 2008 Jun; 54(8):1254-63. PubMed ID: 18455739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NMDA receptor antagonist MK-801 does not protect against serotonin depletions caused by high doses of DL-fenfluramine.
    Sabol KE; Richards JB; Seiden LS
    Brain Res; 1992 Jun; 582(1):129-33. PubMed ID: 1386771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons.
    McCann UD; Ricaurte GA
    Brain Res; 1991 Apr; 545(1-2):279-82. PubMed ID: 1860050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotoxicity of MDMA: neurochemical effects.
    Schmidt CJ; Kehne JH
    Ann N Y Acad Sci; 1990; 600():665-80; discussion 680-1. PubMed ID: 1979217
    [No Abstract]   [Full Text] [Related]  

  • 35. Glial cell response to 3,4-(+/-)-methylenedioxymethamphetamine and its metabolites.
    Herndon JM; Cholanians AB; Lau SS; Monks TJ
    Toxicol Sci; 2014 Mar; 138(1):130-8. PubMed ID: 24299738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Finnegan KT; Skratt JJ; Irwin I; Langston JW
    Neurosci Lett; 1989 Nov; 105(3):300-6. PubMed ID: 2574428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine.
    Baldwin HA; Colado MI; Murray TK; De Souza RJ; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):590-6. PubMed ID: 8467354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
    McCann UD; Yuan J; Ricaurte GA
    Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog.
    Johnson M; Hanson GR; Gibb JW
    Eur J Pharmacol; 1989 Jun; 165(2-3):315-8. PubMed ID: 2570704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture.
    Walker TM; Davenport-Jones JE; Fox RM; Atterwill CK
    Cell Biol Toxicol; 1999 Jun; 15(3):137-42. PubMed ID: 10580546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.